Cholangitis and cholecystitis are two of the most common biliary tract diseases and are often confused for one another. Cholangitis is an inflammation of the bile ducts, while cholecystitis is an inflammation of the gallbladder. Both of these conditions can cause severe pain and other symptoms, so it is important for doctors to be able to distinguish between them. In this article, we will discuss the differences between cholangitis and cholecystitis, as well as the symptoms, causes, and treatments for each condition.
Cholangitis is an inflammation of the bile ducts. The bile ducts are responsible for carrying bile from the liver to the small intestine, where it is used to help digest food. When the bile ducts become inflamed, the bile cannot flow properly and can cause a buildup of bile in the liver and gallbladder. This can lead to an infection, or cholangitis. The most common symptom of cholangitis is severe abdominal pain, usually located in the upper right side of the abdomen. Other symptoms may include fever, chills, nausea, vomiting, jaundice, and dark urine.
Cholangitis is usually caused by an infection, such as a bacterial, viral, or fungal infection. It can also be caused by a blockage in the bile ducts, such as a gallstone or tumor. In some cases, cholangitis can be caused by an autoimmune disorder, such as primary sclerosing cholangitis.
The treatment for cholangitis depends on the underlying cause. If an infection is the cause, antibiotics may be prescribed to treat the infection. If a blockage is the cause, it may need to be removed surgically. In some cases, medication may be prescribed to reduce inflammation and pain.
Cholecystitis is an inflammation of the gallbladder. The gallbladder is a small organ located in the upper right side of the abdomen that stores bile. When the gallbladder becomes inflamed, the bile cannot flow properly and can cause a buildup of bile in the liver and gallbladder. This can lead to an infection, or cholecystitis. The most common symptom of cholecystitis is severe abdominal pain, usually located in the upper right side of the abdomen. Other symptoms may include fever, chills, nausea, vomiting, jaundice, and dark urine.
Cholecystitis is usually caused by an infection, such as a bacterial, viral, or fungal infection. It can also be caused by a blockage in the gallbladder, such as a gallstone or tumor. In some cases, cholecystitis can be caused by an autoimmune disorder, such as primary sclerosing cholangitis.
The treatment for cholecystitis depends on the underlying cause. If an infection is the cause, antibiotics may be prescribed to treat the infection. If a blockage is the cause, it may need to be removed surgically. In some cases, medication may be prescribed to reduce inflammation and pain.
The main difference between cholangitis and cholecystitis is the location of the inflammation. Cholangitis is an inflammation of the bile ducts, while cholecystitis is an inflammation of the gallbladder. Both conditions often cause similar symptoms, such as severe abdominal pain, fever, chills, nausea, vomiting, jaundice, and dark urine. However, the underlying causes and treatments for the two conditions may be different.
Cholangitis and cholecystitis are two of the most common biliary tract diseases and can cause severe pain and other symptoms.
1.
Even when they are not paying attention, children are still learning.
2.
Survivors of high-risk neuroblastoma face substantial late effects of modern therapies
3.
Kate Middleton Reaches Cancer Treatment Milestone
4.
Pulled Myeloma Drug Improves Survival in Trial
5.
Genetics and Genetic Testing to Inform Myelofibrosis Clinical Management.
1.
Breast Cancer Secrets: AI-Powered Precision Medicine
2.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
3.
Surprising Symptoms of Prostate Cancer: What You Need to Know
4.
Empowering Lung Cancer Diagnosis Through the Synergy of Advanced Technologies and Artificial Intelligence
5.
Artificial Intelligence in Oncology: Current Trends, Challenges and Future Outlook
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
3.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
5.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation